The First Affiliated Hospital Of Soochow University

This study is testing whether N-acetylcysteine (NAC), a safe and affordable drug, can treat a severe and potentially fatal blood vessel complication that can happen after a stem cell transplant. It will enroll 44 adult patients who have developed this condition, called TA-TMA, to…

This study tests a two-pronged immune cell therapy for adults with high-risk multiple myeloma, a serious blood cancer. After receiving their own stem cell transplant, patients get specially modified T-cells designed to attack cancer by targeting two proteins (CD19 and BCMA). Rese…

This study is testing whether a combination of three drugs—chidamide, azacitidine, and the HAG regimen—can help control acute myeloid leukemia (AML) in adults when the cancer has come back or hasn't responded to previous treatments. The main goal is to see how well this combinati…

This study is testing a new, personalized treatment for non-small cell lung cancer (NSCLC). Researchers create a tiny vaccine from a patient's own tumor to train their immune cells to attack the cancer. These trained cells are then given back to the patient to see if they can fin…

This study is testing a new type of PET/CT scan designed to better visualize solid tumors that have high levels of a specific protein called Nectin-4. The scan uses a special tracer that attaches to this protein, potentially helping doctors see the tumors more clearly. The goal i…

This study aims to understand what happens to people diagnosed with early-stage blood cell disorders called ICUS and CCUS. Researchers will follow 300 patients in China over time to see if and how these conditions progress to more serious blood diseases like myelodysplastic syndr…